The Medicines (Products for Animal Use—Fees) Regulations 2004

This section has no associated Explanatory Memorandum

1.  Where the manufacture, assembly, sale or supply of products of a particular class or description will be, or is likely to be, interrupted for a period, and in consequence thereof the health of animals will be, or is likely to be put at risk, the relevant authority may determine that any fees payable under these Regulations—

(a)in connection with an application for the grant, variation or renewal of a marketing authorisation or product licence relating to such products; or

(b)in respect of any inspection made during the currency of such a marketing authorisation or product licence,

shall be waived during that period or, if the period will or is likely to exceed 3 months, during the first 3 months.